These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11432964)

  • 1. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.
    Tassone F; Hagerman RJ; Taylor AK; Hagerman PJ
    J Med Genet; 2001 Jul; 38(7):453-6. PubMed ID: 11432964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
    Salat U; Bardoni B; Wöhrle D; Steinbach P
    J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.
    Tassone F; Hagerman RJ; Loesch DZ; Lachiewicz A; Taylor AK; Hagerman PJ
    Am J Med Genet; 2000 Sep; 94(3):232-6. PubMed ID: 10995510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male.
    Han XD; Powell BR; Phalin JL; Chehab FF
    Am J Med Genet A; 2006 Jul; 140(13):1463-71. PubMed ID: 16761284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.
    Tassone F; Hagerman RJ; Taylor AK; Gane LW; Godfrey TE; Hagerman PJ
    Am J Hum Genet; 2000 Jan; 66(1):6-15. PubMed ID: 10631132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
    Kenneson A; Zhang F; Hagedorn CH; Warren ST
    Hum Mol Genet; 2001 Jul; 10(14):1449-54. PubMed ID: 11448936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
    Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Mol Autism; 2019; 10():21. PubMed ID: 31073396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.
    Primerano B; Tassone F; Hagerman RJ; Hagerman P; Amaldi F; Bagni C
    RNA; 2002 Dec; 8(12):1482-8. PubMed ID: 12515381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternal transmission of fragile X syndrome.
    Zeesman S; Zwaigenbaum L; Whelan DT; Hagerman RJ; Tassone F; Taylor SA
    Am J Med Genet A; 2004 Aug; 129A(2):184-9. PubMed ID: 15316964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism, FXTAS, and FMR1 premutations.
    Toft M; Aasly J; Bisceglio G; Adler CH; Uitti RJ; Krygowska-Wajs A; Lynch T; Wszolek ZK; Farrer MJ
    Mov Disord; 2005 Feb; 20(2):230-3. PubMed ID: 15390127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of FMR1 transcript and protein levels among 74 premutation carriers.
    Peprah E; He W; Allen E; Oliver T; Boyne A; Sherman SL
    J Hum Genet; 2010 Jan; 55(1):66-8. PubMed ID: 19927162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients.
    Grasso M; Faravelli F; Lo Nigro C; Chiurazzi P; Sperandeo MP; Argusti A; Pomponi MG; Lecora M; Sebastio GF; Perroni L; Andria G; Neri G; Bricarelli FD
    Am J Med Genet; 1999 Jul; 85(3):311-6. PubMed ID: 10398249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.
    Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R
    Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significantly Elevated
    Field M; Dudding-Byth T; Arpone M; Baker EK; Aliaga SM; Rogers C; Hickerton C; Francis D; Phelan DG; Palmer EE; Amor DJ; Slater H; Bretherton L; Ling L; Godler DE
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical involvement and protein expression in individuals with the FMR1 premutation.
    Tassone F; Hagerman RJ; Taylor AK; Mills JB; Harris SW; Gane LW; Hagerman PJ
    Am J Med Genet; 2000 Mar; 91(2):144-52. PubMed ID: 10748416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FMR1 mRNA from full mutation alleles is associated with ABC-C
    Baker EK; Arpone M; Kraan C; Bui M; Rogers C; Field M; Bretherton L; Ling L; Ure A; Cohen J; Hunter MF; Santa María L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende A; Amor DJ; Godler DE
    Sci Rep; 2020 Jul; 10(1):11701. PubMed ID: 32678152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.